Carbidopa and benserazide have been described as inhibitors of dopa decarboxylase and both have been used in the treatment of Parkinson's disease. Because of their chemical structure as polyphenols, these compounds can behave as substrates of tyrosinase and peroxidase. We demonstrate that these enzymes oxidize both substrates. Since o-quinones are unstable, a chronometric method for enzymatic initial rate determinations was used based on measurements of the lag period in the presence of micromolar concentrations of ascorbic acid to kinetically characterize these substrates. In the case of tyrosinase, the values of the Michaelis constant for both substrates were greater than those described for dopa, although the catalytic constants were lower, probably due to the greater size of the substitute group in carbon 1. As regards peroxidase, the saturation of the enzyme by both substrates is possible, however this effect does not occur with the isomers of dopa. The distance of the charges from the benzene ring may enable the ring to approach the iron of the active site and, therefore, act.
Tyrosinase (TYR; EC 1.14.18.1) is a type-3 copper protein, which contains a binuclear copper cluster consisting of two copper atoms coordinated by 3 histidines, and is ubiquitously present in biological systems. 1, 2) It catalyzes the regioselective orthohydroxylation of monophenols to catechols (monophenolase or cresolase activity). It also catalyzes the oxidation of o-diphenols to the corresponding o-quinones by the consumption of molecular oxygen (o-diphenolase or catecholase activity).
Peroxidases are ubiquitous in the plant and animal kingdoms.
3) The cationic isoenzyme from horseradish peroxidase (EC 1.11.1.7; POD) has been studied intensively because of its commercial use in diagnostic assays and its potential application in bioremediation. 4) The oxidation of phenols by POD produces extremely reactive free radical intermediates which, following release from the enzyme, readily condense to yield polymeric products of variable stoichiometry. Because of this, the kinetics of these reactions was not described by classical Michaelis-Menten equations for a long time. However, when a suitable method was found, it became possible to establish the typical Michaelis-Menten kinetics with a series of o-diphenols, monophenols, and anilines. 4) L-DOPA is central in the melanin synthetic pathway and in vivo studies have suggested that L-DOPA may be cytotoxic to melanoma cells through the intracellular accumulation of toxic melanin intermediates. 5 ) L-DOPA is used to treat Parkinson's disease but it must first cross the hematocephalic barrier. However, in the peripheral system, l-dopa is decarboxylated and transformed into dopamine, which cannot cross the above barrier. To diminish the quantity of L-DOPA that is transformed into dopamine in the peripheral system, and thereby increase the quantity that crosses the blood-brain barrier and which decarboxylates inside the central system, a series of inhibitors of dopa decarboxylase (which is the key enzyme in L-DOPA decarboxylation and other amino acids), such as cardidopa or benserazide, is added along with L-DOPA. This is done by means of drugs such as madopar Ò (dopa/benserazide) or sinemet Ò (dopa/carbidopa) respectively. Since both cardidopa and benserazide increase plasma levels of L-DOPA, they have also been used to treat malignant melanoma. 5, 6) However, these drugs may also have secondary effects such as activating malignant melanoma in people with a history of melanoma, or causing skin lesions which might well be malignant due to the dose of L-DOPA they contain. They may also cause respiratory alterations (arrhythmias), increased depression, or psychosis due to the increased concentration of dopamine in the organism, arterial hypertension, renal insufficiency, etc. Dopa decarboxylase or aromatic L-amino acid decarboxylase (EC 4.1.1.28) is the enzyme which catalyzes the rate-limiting step in the decarboxylation of aromatic L-amino acids, such as L-DOPA to dopamine (neuroy To whom correspondence should be addressed. Fax: +34-968-363963; E-mail: canovasf@um.es Abbreviations: TYR, tyrosinase; POD, peroxidase; S, substrate, carbidopa or benserazide; Q, quinone of S; AH 2 , ascorbic acid; A, dehydroascorbic acid; L-DOPA, L-3,4 dihydroxyphenyl alanine; V transmitter), 5-hydroxytryptamine to serotonine (neurotransmitter), or tryptophan to tryptamine (a precursor to many alkaloids found in plants and animals).
Since benserazide and carbidopa have a diphenolic structure (Scheme 1), they can be oxidized by tyrosinase and peroxidase. In this work, we proposed to kinetically characterize the oxidation of these compounds as possible substrates of these enzymes, commonly used as model enzymes in processes such as melanin biosynthesis. [7] [8] [9] Material and Methods
Reagents. Mushroom tyrosinase (1,530 U mg À1 ), horseradish peroxidase (297 U mg À1 ), benserazide, and carbidopa were obtained from Sigma Chemical (St. Louis, MO). Stock solutions of the reducing substrates were prepared in 0.15 mM phosphoric acid to prevent autooxidation. The structures of benserazide and carbidopa are depicted in Scheme 1. The buffers used were 30 mM (pH 7.0) sodium phosphate buffer at C 25 for benserazide, and 30 mM (pH 6.0) sodium phosphate buffer at C 25 for carbidopa, due to its instability and rapid cyclation at pH 7.0.
Enzyme source. Mushroom tyrosinase (1,530 U mg À1 ; TYR) was purified by Duckworth and Coleman's procedure, but with two additional chromatographic steps.
10) The enzyme solution was passed through a column (2:0 Â 30 cm) of Sephadex G-100 (Pharmacia, Upsala, Sweden) equilibrated on 0.01 M sodium phosphate buffer (pH 7). Samples showing tyrosinase activity were further purified by FPLC anion-exchange chromatography on a Mono-Q HR 5/5 column (2:0 Â 30 cm) (Pharmacia) equilibrated with 0.01 M sodium phosphate (pH 7) and eluted with sodium chloride (0-0.5 M gradient). Purified enzyme was desalted with Sephadex G-25 (Pharmacia) into ultrapure water and stored in liquid nitrogen. Horseradish peroxidase (297 U mg À1 ; POD) was purchased from Sigma (type VI; Rz ¼ 3:2) and used without further purification. The concentration of POD was determined spectrophotometrically using a Soret molar absorptivity of 102 mM À1 cm À1 . 4) The protein concentration was determined (for TYR and POD) by Bradford's method, 11) using bovine serum albumin as the standard.
Spectrophotometric assays. Absorption spectra were recorded in a visible-ultraviolet Perkin-Elmer Lambda 35-spectrophotometer interfaced on-line with a PC compatible microcomputer, at a scanning speed of 60 nm/s. The temperature was controlled at C 25 using a Haake D16 circulating water bath with a heater/cooler, and checked using a Cole-Parmer digital thermometer with a precision of AE0:1 C. Kinetic assays were also carried out with the above instruments following a chronometric method by measuring the appearance of the products in the reaction medium. Reference cuvettes contained all the components, except the substrate, in a final volume of 1 ml. For TYR, all the assays were carried out under saturating conditions of TYR by molecular oxygen (0.26 mM oxygen in the assay medium). 10, 12) In the case of POD, the H 2 O 2 concentration was saturating (1 mM) (see Table 1 ).
Chronometric method. Enzymatic activity was determined spectrophotometrically using the chronometric method described in refs. 4 and 13. Briefly, the method uses ascorbic acid (AH 2 ), which is capable of reducing the products of both enzymes (o-quinones in the case of tyrosinase (TYR) and free radicals, semiquinones, in the case of POD). Once the AH 2 has been consumed, an absorbance signal should appear due to the presence of the above products, from which the time necessary, , to consume the quantity of AH 2 called [AH 2 ] 0 can be determined. From these values, the initial rate, V 0 , can be determined (see ''Results and Discussion''). Preliminary experiments were carried out in the absence of ascorbic acid with the TYR/O 2 /S system by recording spectrophotometric scans to identify in which zone of the spectrum, particularly the visible zone, the greatest changes in absorbance occurred. The wavelength chosen at both pH was 360 nm. The activity of horseradish peroxidase (POD) was continued using the same methodology, but with the POD/H 2 O 2 /S system. 
Kinetic data analysis. Tyrosinase (TYR). Initial rate values (V

Results and Discussion
Kinetic characterization of the oxidation of carbidopa and benserazide by TYR and POD
To characterize carbidopa and benserazide as substrates of TYR and POD, the initial slope of the appearance of Product vs. t (V 0 ) was measured directly at 360 nm ( Figs. 1 and 2 ). However, these recordings did not provide the hyperbolas necessary to estimate V max and K m when V 0 is represented vs.
[S] 0 ( Fig. 1 Inset and Fig. 2 Inset). As can be appreciated from these graphs, false activations may become apparent at high substrate concentrations and due to the instability of the products generated both with TYR ( Fig. 1) and POD (Fig. 2) for carbidopa and benserazide, respectively.
In some cases where the o-quinones generated by TYR and POD are unstable, the use of a reductant, such as AH 2 , which instantaneously reduces to Q, has been proposed to follow the enzymatic activity; this enables the disappearance of the AH 2 to be followed spectrophotometrically.
13) However, it was not possible to follow the disappearance of AH 2 by referring to the overlapping spectra of S and AH 2 at the different pH values used, for which reason we used a chronometric method, which was previously described to determine the enzymatic activity on substrates producing unstable o-quinones, 4, 13) based on measurement of the time required for the consumption of a small quantity of AH 2 , sufficient to prevent Q from evolving, according to the following Scheme for TYR: 10) where E m , E d and E ox represent the oxidized and deoxygenated forms and a form with a peroxide group of the enzyme, respectively. Substrate is represented as S (Scheme 2).
This method uses the reduction by AH 2 of the product (Scheme 2d), which is generated by the enzyme (Scheme 2a-c) .
10) The true steady-state initial rate, 
The term V 0 t means the matter generated by the enzyme in the form of o-quinone or semiquinone in its action on substrate (TYR or POD). The intersection of the increase in absorbance of the recording Q vs. t and the time axis corresponds to Q ¼ 0 and t ¼ (lag period, Figs. 3 and 4) . Thus, Eq. (1) is transformed into:
and so, in the case of TYR:
Therefore, if we can experimentally determine , and it [AH 2 ] 0 is known, V TYR 0 can be calculated according to Eq. (3). The value of can be experimentally determined if a spectrophotometric signal indicates that AH 2 has been consumed (see Fig. 3 ).
In the case of POD, in agreement with the stoichiometry of Scheme 3, the expression of
TYR is saturated by oxygen, 12) and, if ½O 2 0 ! 1, the expression of V TYR 0 , in agreement with Scheme 2, is given by:
where
Due to the absence of rapid equilibrium in the oxidation of o-diphenols by met-tyrosinase and oxytyrosinase, k 7 ) k À6 and k 3 ) k À2 .
10) From a presteady-state experiment, was determined that k 2 ) k 6 , 10) and therefore, from Eq. (7):
When the enzyme is saturated by the substrate S and not by O 2 , the expression of V TYR 0 is:
Knowing k
TYR cat
for the reaction of TYR with a substrate and since k 8 is (ð2:3 AE 0:4Þ Â 10 7 M À1 s À1 ), 10) the value of K O 2 m can be obtained (see Table 1 ). From Eq. (8) for TYR, it is possible to calculate k 6 , the binding rate constant of the substrate to the form E ox (see Table 1 ).
The action of POD on reducing substrates (S) in the presence of H 2 O 2 is described by Scheme 3:
4) where 
vs.
[carbidopa] 0 , directly measuring the appearance of product for POD.
Scheme 2. Kinetic Mechanism of the Action of TYR.
POD indicates that free enzyme, POD-I, is compound I, POD-II, is compound II, and SQ-S is the semiquinone radical corresponding to S. The kinetic analysis of the mechanism shown in Scheme 3, 4) results at saturating concentrations of H 2 O 2 in:
and
When POD is saturated by the substrate S, the V POD 0 expression is:
If in the mechanism shown in Scheme 3, and from data found in the literature,
and K S,POD m are given after rearrangement by:
The value of k 1 is 1: . The binding rate constant of the substrate to compound II, k 5 , can be calculated from Eq. (18) ( Table 1) . Therefore, the analysis of the data according to Eqs. (11)- (18) provides the kinetic information shown in Table 1 ( Fig. 4 and Inset). 
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Scheme 3. Kinetic Mechanism of the Action of POD. and, therefore, they should be determined experimentally by applying the integrated Michaelis equation:
For the oxidation of cabidopa by TYR/O 2 , O 2 consumption curves can be obtained (Fig. 5a ), which can be analyzed with Eq. (19) (Fig. 5 Inset) . In the oxidation of benserazide by TYR/O 2 , the O 2 consumption recordings are predominantly linear (Fig. 5b) Comments on the kinetic constants When the chronometric method described above was applied to the kinetic characterization of these substrates (carbidopa or benserazide), a hyperbolic dependence of V 0 vs. [S] 0 was obtained (Fig. 3 inset for TYR and Fig. 4 inset for POD). 13) Analysis of the data, as described in 66 Materials, and Methods 99 , provided the information summarized in Table 1 for TYR and POD.
From these results (Table 1) , it can be concluded that both substrates (carbidopa and benserazide) are worse substrates than L-DOPA for TYR.
10) The catalytic constant for TYR, k TYR cat was lower than that of the physiological substrate L-DOPA. The Michaelis constant values were higher than for L-DOPA, while the Michaelis constants for oxygen were very low, in agreement with Eq. (10) . These data as a whole (Table 1) may be explained by the steric hindrance caused by the large size of the group in C-1.
The kinetic constants of POD with respect to these substrates are good and even better than those determined for L-DOPA. 4) Note how L-DOPA could not saturate the enzyme and so only the attack constant of the substrate on POD-II, k 5 could be calculated. 4) However, due to the chain in C-1, these substrates could have charges far from the benzene ring, which may favour access to the active site and so enable them to saturate the enzyme since there is a hydrophobic channel, with several phenylanalines, in the active site of this enzyme (Phe 68 , Phe 179 and Phe 142 ) (see Table 1 ).
In conclusion, the kinetic characterization of carbidopa and benserazide (dopa decarboxylase inhibitors) shows them to better substrates of peroxidase than L-DOPA, while the opposite is true in the case of tyrosinase. 
